Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eve Leconte

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Lifetime Data Analysis|August 17, 2002
Smooth conditional distribution function and quantiles under random censorshipEve Leconte, Sandrine Poiraud-Casanova, Christine Thomas-Agnan
Urologic Oncology|April 4, 2016
Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approachSerge M A Somda, Dalenc Florence, Eve Leconte, et al.
Computers in Biology and Medicine|August 14, 2018
Focus on an infrequently used quantity in the context of competing risks: The conditional probability functionBastien Cabarrou, Florence Dalenc, Eve Leconte, et al.
BMC Medical Research Methodology|October 27, 2022
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trialsBastien Cabarrou, Eve Leconte, Patrick Sfumato, et al.
Statistical Methods in Medical Research|February 26, 2014
Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapsesSerge Ma Somda, Eve Leconte, Jean-Marie Boher, et al.
Computational and Mathematical Methods in Medicine|July 17, 2020
Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional SettingsJulia Gilhodes, Florence Dalenc, Jocelyn Gal, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell TumorsSerge M A Somda, Stéphane Culine, Christine Chevreau, et al.
Computers in Biology and Medicine|October 28, 2017
Comparison of variable selection methods for high-dimensional survival data with competing eventsJulia Gilhodes, Christophe Zemmour, Soufiane Ajana, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 2, 2013
Determining the length of posttherapeutic follow-up for cancer patients using competing risks modelingSerge M A Somda, Eve Leconte, Andrew Kramar, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2018
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncologyBastien Cabarrou, Patrick Sfumato, Loïc Mourey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lifetime Data Analysis|August 17, 2002
Smooth conditional distribution function and quantiles under random censorshipEve Leconte, Sandrine Poiraud-Casanova, Christine Thomas-Agnan
Urologic Oncology|April 4, 2016
Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approachSerge M A Somda, Dalenc Florence, Eve Leconte, et al.
Computers in Biology and Medicine|August 14, 2018
Focus on an infrequently used quantity in the context of competing risks: The conditional probability functionBastien Cabarrou, Florence Dalenc, Eve Leconte, et al.
BMC Medical Research Methodology|October 27, 2022
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trialsBastien Cabarrou, Eve Leconte, Patrick Sfumato, et al.
Statistical Methods in Medical Research|February 26, 2014
Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapsesSerge Ma Somda, Eve Leconte, Jean-Marie Boher, et al.
Computational and Mathematical Methods in Medicine|July 17, 2020
Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional SettingsJulia Gilhodes, Florence Dalenc, Jocelyn Gal, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell TumorsSerge M A Somda, Stéphane Culine, Christine Chevreau, et al.
Computers in Biology and Medicine|October 28, 2017
Comparison of variable selection methods for high-dimensional survival data with competing eventsJulia Gilhodes, Christophe Zemmour, Soufiane Ajana, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 2, 2013
Determining the length of posttherapeutic follow-up for cancer patients using competing risks modelingSerge M A Somda, Eve Leconte, Andrew Kramar, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2018
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncologyBastien Cabarrou, Patrick Sfumato, Loïc Mourey, et al.
Pageof 1